Dishman Carbogen Amcis Q3 Results
- BSE: 540701
- NSE: DCAL
- ISIN: INE385W01011
- Sector: Biotechnology & Drugs
BSE
186.70
-5.95 (-3.09%)
-5.95 (-3.09%)Volume34.62 K
Updated: Fri 8 May, 2026 | 15:29:47
NSE
187.25-4.98 (-2.59%)
-4.98 (-2.59%)Volume1.94 L
Updated: Fri 8 May, 2026 | 15:43:53
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹719.80 Cr.(5.49%)
- Operating Profit₹28.69 Cr.(-59.13%)
- Profit After Tax₹-12.97 Cr.(NA%)
- Operating Margin3.99%(-61.26%)
Note: Comparison is on YoY basis
Quarterly - Dishman Carbogen Amcis Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 691.11 | 716.94 | 17.56% | 690.35 | 12.90% |
| Depreciation/ Amortization | 84.42 | 72.09 | 0.34% | 80.37 | 17.30% |
| Operating Income | 28.69 | 72.10 | -55.70% | -39.26 | -59.13% |
| Net Income | -12.97 | 33.09 | 0.00% | -59.63 | 0.00% |
| Other Operating Expenses Total | 109.33 | 130.29 | -19.91% | 181.20 | -1.30% |
| Net Income Before Taxes | -10.44 | 42.12 | 0.00% | -66.29 | 0.00% |
| Total Revenue | 719.80 | 789.04 | 10.29% | 651.09 | 5.49% |
| Selling/ General/ Admin Expenses Total | 355.88 | 319.73 | 6.89% | 309.20 | 7.17% |
| Diluted Normalized EPS | -0.83 | 2.26 | 0.00% | -3.74 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.